ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. ArisGlobal end-to-end drug development technology platform, LifeSphere®, integrates ArisGlobal proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® boosts efficiency, ensures compliance and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together more effectively using common technology. The suite of StudyTeam solutions reduces site burden and helps sites pre-screen and enroll more patients, provides sponsors with end-to-end visibility into recruitment activity across all channels, and guides sites in conducting the trial for patients who have been enrolled. StudyTeam is trusted by the largest global biopharmaceutical companies, used in over 7,000 research sites, and is available in over 100 countries. One mission. One team. That’s OneStudyTeam.
Teckro connects investigators and research site staff, sponsors and monitors with both each other, and the critical study information they need, when they need it. A digital clinical trial hub of content, communication and collaboration, Teckro transforms the clinical trial protocol from a static document into a critical data source for engagement and trial conduct. Global pharmaceuticals and emerging biotechnology companies alike rely on Teckro for all trial phases and therapeutic areas. Headquartered in Limerick, Ireland, Teckro has locations across Europe and the United States.